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Autophagy diminishes the early interferon-
β response to inﬂuenza A virus resulting in
differential expression of interferon-
stimulated genes
Brieuc P. Perot1,2,3, Jeremy Boussier1,2,4,5, Nader Yatim1,2, Jeremy S. Rossman 6, Molly A. Ingersoll1,2 and
Matthew L. Albert 1,2,7
Abstract
Inﬂuenza A virus (IAV) infection perturbs metabolic pathways such as autophagy, a stress-induced catabolic pathway
that crosstalks with cellular inﬂammatory responses. However, the impact of autophagy perturbation on IAV gene
expression or host cell responses remains disputed. Discrepant results may be a reﬂection of in vivo studies using cell-
speciﬁc autophagy-related (Atg) gene-deﬁcient mouse strains, which do not delineate modiﬁcation of developmental
programmes from more proximal effects on inﬂammatory response. In vitro experiments can be confounded by gene
expression divergence in wild-type cultivated cell lines, as compared to those experiencing long-term absence of
autophagy. With the goal to investigate cellular processes within cells that are competent or incompetent for
autophagy, we generated a novel experimental cell line in which autophagy can be restored by ATG5 protein
stabilization in an otherwise Atg5-deﬁcient background. We conﬁrmed that IAV induced autophagosome formation
and p62 accumulation in infected cells and demonstrated that perturbation of autophagy did not impact viral
infection or replication in ATG5-stablized cells. Notably, the induction of interferon-stimulated genes (ISGs) by IAV was
diminished when cells were autophagy competent. We further demonstrated that, in the absence of ATG5, IAV-
induced interferon-β (IFN-β) expression was increased as compared to levels in autophagy-competent lines, a
mechanism that was independent of IAV non-structural protein 1. In sum, we report that induction of autophagy by
IAV infection reduces ISG expression in infected cells by limiting IFN-β expression, which may beneﬁt viral replication
and spread.
Introduction
Macroautophagy (hereafter referred to as autophagy) is
a catabolic pathway conserved among eukaryotes by
which cytoplasmic elements are isolated within double-
membrane autophagosomes that mature by fusing with
the endo-lysosomal compartment1. The elongation of
autophagosome membranes requires two ubiquitin-like
conjugation systems1. First, autophagy-related 5 (ATG5)
is conjugated to ATG12, which is required for formation
of the second complex composed of phosphatidyletha-
nolamine (PE) conjugated to microtubule-associated
protein 1 light chain-3 (LC3). Free cytosolic LC3 is
referred to as LC3-I, whereas the PE-conjugated form is
termed LC3-II. Autophagy occurs in all nucleated cells,
playing a key role in maintaining homeostasis2. In stress
conditions, such as viral infection, autophagic activity may
increase3–5.
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Autophagy can increase or decrease viral ﬁtness
depending on the virus or model system studied6. One
direct antiviral action mediated by autophagy is the
degradation of viral components7. Autophagy can also
alter antiviral cell pathways, including programmed cell
death, sensing of virus-associated molecular patterns and
cytokine secretion4, 8. For example, autophagy supports
hepatitis C virus (HCV) replication and negatively reg-
ulates interferon-β (IFN-β) induction during HCV infec-
tion9–12.
Inﬂuenza A virus (IAV), a member of the Orthomyx-
oviridae family, causes yearly epidemic infections and
sporadic pandemics. IAV-related symptoms are mainly
the result of excessive inﬂammation including high levels
of pro-inﬂammatory cytokines13. IAV virus-associated
molecular patterns are sensed by Toll-like receptors,
nucleotide oligomerization domain-like receptors and
retinoic acid-induced gene I (RIG-I)-like receptors, which
induce type I IFN and pro-inﬂammatory cytokine secre-
tion14. IAV has evolved mechanisms to antagonize innate
immune responses in infected cells, mainly via non-
structural protein 1 (NS1), which inhibits RIG-I signal-
ling14. While IAV stimulates autophagy, its matrix protein
2 (M2) has been proposed to block the maturation of
autophagosomes, although this ﬁnding remains dis-
puted15–18.
We investigated the impact of IAV-mediated autophagy
perturbation on the host cell response to infection. We
designed our study to circumvent limitations of techni-
ques commonly used to study autophagy. Notably, che-
mical treatments used to manipulate autophagy impact
other biological processes. For example, rapamycin, used
to inhibit autophagy, inhibits the kinase activity of the
mammalian target of rapamycin, impacting transcription,
translation and mitochondrial metabolism19. Transfection
of small interfering RNAs (siRNAs) to suppress autophagy
genes can activate innate signalling pathways in a struc-
ture- or sequence-dependent manner20. Knockout (KO)
or siRNA knockdown cell lines are subject to genetic drift,
with compensatory mutations resulting in unanticipated
off-target effects when compared to wild-type (WT) cell
lines21–23. Finally, the ATG5 tet-off cell system is prone to
bias due to the requirement of long-term exposure to
doxycycline to repress autophagy24. Notably, doxycycline
and related antibiotics can alter mitochondrial function,
inﬂammation, proliferation, metabolism and, in some
instances, induce cell death25–33.
We generated a new experimental model in which the
capacity to undergo autophagy can be controlled through
drug-induced stabilization of critical components of the
autophagy pathway that are otherwise targeted for
degradation. Importantly, this model does not induce
autophagy but instead restores the capacity of a cell to
undergo autophagy. We observed that autophagy was
dispensable for IAV replication, but cells lacking a func-
tional autophagy pathway had an enhanced type I IFN-
induced inﬂammatory response at early time points post-
infection. Together, our ﬁndings clarify the interplay of
IAV infection, autophagy and host response. Moreover,
the experimental model presented herein will establish a
new path towards validating the role of autophagy during
inﬂammatory processes.
Results
A novel model to initiate autophagy through the induced
stabilization of ATG5
Many experimental systems used to study autophagy
result in off-target effects due to the disruption of
bystander pathways. To avoid potential confounding
artefacts, we generated novel expression systems and cell
lines in which autophagy can be controlled through the
induced stabilization of ATG5. We generated clonal
populations of Atg5–/– mouse embryonic ﬁbroblasts
(MEFs) that stably expressed the ATG5 protein fused to a
destabilization domain (ATG5DD), which is known to be
rapidly degraded by the proteasome (Fig. 1a)34. The small,
biologically inert, cell-permeable molecule, Shield1,
interacts with the destabilization domain, preventing its
degradation by the proteasome34, 35. Addition of Shield1
to Atg5–/– MEFs expressing ATG5DD rescued the degra-
dation of the ATG5DD fusion protein (Fig. 1b). Notably,
accumulated ATG5DD protein was primarily found within
ATG5–ATG12 complexes, supporting that the fusion
protein retained this function (Fig. 1b). Intra-incubator
microscopy was used to measure cell conﬂuence over
time, with or without the addition of Shield1, revealing
that ATG5DD accumulation, in nutrient-rich conditions,
did not impact the kinetics of cell growth (Fig. 1c).
We next tested whether ATG5DD stabilization restored
the ability of the cell to undergo autophagy, as determined
by the conversion of LC3-I to LC3-II, a measure of
autophagosome and autophagolysosome accumulation36.
Shield1 rescued basal autophagy as early as 1 h post
addition (Fig. 1d). As expected, untreated ATG5DD cells
were phenotypically similar to the parental Atg5–/– cell
line. Both lines exhibited low levels of LC3-II conversion;
however, following Shield1 treatment, modest levels of
LC3-II could be detected in the ATG5DD cell line, similar
to the levels of autophagy in WT cells (Fig. 1e). Further-
more, we observed that inducing autophagy by serum
starvation or PP242 treatment or inhibiting autophago-
lysosome function using chloroquine led to increased
LC3-II/LC3-I ratios within Shield1-treated cells (Fig. 1e).
We also measured p62 expression, an adaptor protein that
is degraded in the course of autophagy and whose accu-
mulation in the presence of high levels of LC3-II is indi-
cative of abortive autophagy36. We demonstrated that p62
levels were reduced following Shield1 treatment, with
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further reduction observed in cells exposed to serum
starvation or PP242 (Fig. 1e). As expected, p62 was not
degraded in autophagy-competent cells that were treated
with chloroquine, which blocks autophagosome fusion
with lysosomes36. As the DD is expected to lead to pro-
teasomal degradation of ATG5DD, we tested whether
proteasome inhibition by MG132 would result in Shield1-
independent ATG5DD accumulation and rescue of
autophagy competence. Indeed, MG132 treatment resul-
ted in p62 degradation in both control and Shield1-
treated cells (Fig. 1e). Together, these data established
that ATG5DD was degraded by the proteasome and that
Shield1 treatment restored the capacity to undergo
autophagy in ATG5DD-expressing Atg5–/– cells. We vali-
dated that our cell-based system rescued autophagy by
testing whether chikungunya virus (CHIKV) propagation
was inhibited upon Shield1 treatment (Fig. 1f)37.
We next assessed autophagy in the context of IAV
infection, exposing ATG5DD cells to IAV A/PR/8/1934
(H1N1, PR8 strain) for 20 h in the presence or absence of
Shield1. Using imaging ﬂow cytometry, we delineated
infected and uninfected cells (Fig. 1g) and measured
autophagic cells within each population (Fig. 1h). IAV-
induced LC3 puncta accumulated in IAV-infected cells
(green) but not in uninfected cells (purple) (Fig. 1i, j).
Overall, LC3-II levels increased when Shield1 was present
during infection (Fig. 1k). Notably, p62 was not degraded
following Shield1 treatment during infection, consistent
with previous reports that IAV inhibits autophagosome
maturation17.
Autophagy does not impact viral infection or replication
As autophagy impacts viral replication in several
infectious models7, 38, we used our inducible cell lines to
investigate the inﬂuence of autophagy on IAV replication.
We found that the IAV RNA content of infected samples
at 5 h post-infection was not different between control
and Shield1-treated cells (Fig. 2a). The expression of
nucleoprotein (NP) in infected cells was measured by ﬂow
cytometry (Fig. 2b). The percentage of NP-expressing
cells was similar between control and Shield1-treated cells
16 h post-infection, at low and higher multiplicities of
infection (MOIs) (Fig. 2c). Moreover, the intensity of NP
expression within IAV-infected cells was unchanged
(Fig. 2d). M2 protein was also expressed at similar levels
(Fig. 2e, f). Finally, haemagglutinin protein and NP RNA
levels in supernatants were similar in autophagy-
competent and -incompetent cells (Fig. 2g, h). Of note,
low levels of LC3-II were observed in the absence of
Shield1 when cells were infected by IAV (Fig. 1j). This is
likely a result of lower levels of proteasome activity, which
in turn permitted modest Atg5 expression. To conﬁrm
that low levels of autophagy were not required for IAV
replication, we infected Atg5–/– MEFs, showing that
autophagy is indeed dispensable for infection (Fig. 2i).
Taken together, these data demonstrate that restoration
of autophagy did not impact IAV infection or replication.
Autophagy limits interferon-stimulated gene (ISG)
induction independently of the key IAV anti-type I IFN
protein NS1
We next wanted to determine whether autophagy
impacts the host response to IAV. To test whether
immune pathways were impacted by autophagy, we used
the NanoString nCounter technology, a method that
allows the quantitative measurement of single mRNA
molecules, without the need for RT or ampliﬁcation. We
measured RNA from a 561 gene set of immunology-
related genes, including cytokine and Toll-like receptor-
related pathways (Supplementary Figure S1). ATG5DD
(see ﬁgure on previous page)
Fig. 1 Stabilization of ATG5 in Atg5–/– cells enables experimental control of autophagy. a Schematic representation of Shield1 (Sh1)
stabilization of ATG5 illustrates the rescue of destabilization domain (DD)-fused ATG5 (ATG5DD). b ATG5DD-expressing Atg5–/– cells were treated with
ethanol vehicle (∅) or Sh1 for 20 h, followed by immunoblot analysis with anti-ATG5 antibody. c ATG5DD-expressing Atg5–/– cells were treated with
Sh1 and images were obtained every hour for 60 h to assess cell growth. Points depict mean conﬂuence at interval time and error bars depict
standard deviation. d ATG5DD-expressing cells were treated for the indicated times with Sh1 or vehicle (∅). Protein extracts were subjected to
immunoblot analysis using anti-LC3 and anti-GAPDH antibodies. e In the presence or absence of Sh1, cells were exposed to serum deprivation, an
inhibitor of the mammalian target of rapamycin (PP242), a proton pump inhibitor (chloroquine, CQ) or a proteasome inhibitor (MG132). Wild-type
(WT) and Atg5–/– MEFs (Atg5–/–) were used as positive and negative controls, respectively. After 4 h of culture, protein extracts were subjected to
immunoblot analysis using anti-p62, anti-LC3 and anti-GAPDH antibodies. f ATG5DD cells, pretreated or not with Shield1 (Sh1), were infected with
GFP-expressing chikungunya virus at an MOI of 0.1. The number of green cells were monitored through live imaging. Graph shows mean and
standard deviation of three biological replicates, and data are representative of three experiments. ns, not signiﬁcant; *q < 0.01, **q < 0.01 (two-tailed
unpaired t-test followed by Holm’s multiple testing correction). g–k ATG5DD expression was stabilized by Sh1 treatment and cells were infected with
inﬂuenza A virus (IAV). After 20 h, cells were ﬁxed, permeabilized and stained using anti-NP antibody to quantify IAV infection and anti-LC3 antibody
to visualize autophagy puncta. Imaging ﬂow cytometry permitted gating based on NP expression (representative dot plot, g) and quantiﬁcation of
autophagic vesicles using the bright detail intensity R3 (BDI R3, histogram, h). i Three representative images of single cells with three different BDI R3,
corresponding to the indicated numbered arrows in h, are shown. The topography of LC3 within cells is shown in red. Scale bar, 10 μm. j Graphs plot
mean percentage of cells with high autophagic vesicle content and standard deviation; analysis is based on images captured from >10,000 cells per
experiment (n= 2 experiments). k Cells were analysed by immunoblot for p62, LC3 and GAPDH expression
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cells, pretreated or not with Shield1 for 16 h, were infected
with IAV for 4 or 12 h. Raw counts were normalized to
the geometric mean value of ﬁve internal control genes
(Ppia, Gapdh, Rpl19, Oaz1 and Polr2a), selected based on
the application of the geNorm method39 (Supplementary
Figure S2 and Materials and methods). From the results of
Fig. 2 (See legend on next page.)
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three independent experiments, we found that the
inability to undergo autophagy during infection led to
higher expression of many pro-inﬂammatory genes as
compared to autophagy-competent cells, including
established ISGs, such as Psmb10, Cd274, Cxcl10, Irf1 and
Tap1 (Fig. 3a and Supplementary Table S1). Of note, two
members of the class I major histocompatibility complex
(MHC I) pathway, Psmb10 and Tap1, were decreased in
autophagy-competent cells (Fig. 3a). To identify biological
processes and signalling pathways, rather than single
genes, impacted by autophagy capacity in a robust fash-
ion, we performed a gene set enrichment analysis
(GSEA)40. Among the 129 gene sets tested (corresponding
to sets from databases that included at least ﬁve genes
measured in this experiment and with expression levels
consistently above the lower limit of quantiﬁcation), we
identiﬁed four pathways that were signiﬁcantly enriched
in genes differentially expressed by autophagy-competent
(Shield1-treated) vs. autophagy-deﬁcient (control vehicle-
treated) infected cells (Fig. 3b), which were ranked by
decreasing order of enrichment: IFN signalling; IFN-α/β
signalling; cytokine signalling; and IFN-γ signalling.
Owing to shared gene expression among IFN-γ and IFN-
α/β signalling pathways, and given that GSEA relies on
unweighted gene set lists, this method is not suitable for
distinguishing between type I and type II IFN responses.
We, therefore, implemented a more quantitative
approach, using recently published data comparing the
gene signature of IFN-β- and IFN-γ-stimulated whole
blood, analysed by the same nCounter technology41. The
genes most signiﬁcantly impacted by autophagy and
present in the gene sets of both our study and the whole
blood approach (44 genes, t-test p-value < 0.05, Supple-
mentary Table S1) were weighted by their t-statistic,
which gave rise to an “autophagy” vector lying in a 44-
gene feature dimensional space. We then used data from
control, IFN-β or IFN-γ whole-blood stimulation of 25
healthy donors to create two new vectors by weighting
each gene by its t-statistic (paired t-test, control vs. IFN-β
or control vs. IFN-γ). All vectors were normalized to
length 1, and the “autophagy” vector was projected onto
the “IFN-β” and “IFN-γ” vectors (Fig. 3c). The scalar
product 〈autophagy, IFN-β〉 was found to be greater than
the 〈autophagy, IFN-γ〉 scalar product. Bootstrapping
over the 25 donors from the whole-blood study conﬁrmed
the robustness of this result, as the difference between the
two scalar products showed a consistent positive value
(95% conﬁdence interval= (0.014, 0.12)), suggesting that
the autophagy signature was more characteristic of sti-
mulation by IFN-β than by IFN-γ (Fig. 3d). Moreover,
Ifnb1 was the only IFN gene consistently detected in our
cellular model after infection (Supplementary Figure S3).
These results indicate that autophagy modulates IFN-β-
stimulated genes following IAV infection.
We next tested whether IAV-induced autophagy
impacted the inﬂammatory response at the protein level.
During IAV infection, C-X-C chemokine motif ligand 10
(CXCL10) secretion was decreased by ATG5DD stabili-
zation, with differential expression between Shield1-
treated and -untreated cells detected as early as 5 h
(Fig. 4a). Furthermore, surface expression of CD274 and
class I major histocompatibility protein H-2Kb were
reduced by ATG5DD stabilization 16 h post-infection
(Fig. 4b, c). Of note, surface expression of H-2Kb was
also signiﬁcantly, although to a lesser extent, impacted by
autophagy in uninfected cells. Additionally, we measured
PSMB10 expression, a subunit of the immunoproteasome,
which was also reduced in autophagy-competent cells
(Fig. 4d). All three of these proteins are induced by type I
IFN42–45 and support the conclusion that IAV-induced
autophagy negatively regulates IFN-β–induced inﬂam-
matory responses. We conﬁrmed that Cd274 was indeed
an ISG by blocking IFN-α/β receptor (IFNAR) signalling
through the use of a neutralizing anti-IFNAR1 antibody
(Fig. 4e). Cd274 was the most differentially expressed ISG
at the RNA level. Therefore, we used this molecule, as
well as H-2Kb expression, as functional readouts of the
impact of autophagy for the remainder of our study. As
autophagy limits vesicular stomatitis virus (VSV)-induced
inﬂammation through dampening of cellular reactive
oxygen species (ROS) content46, we tested whether
restoring autophagy capacity led to changes in cellular
(see ﬁgure on previous page)
Fig. 2 ATG5 stabilization does not impact IAV replication. a Following 5 h infection, with or without Shield1 (Sh1) pretreatment, IAV RNA
expression levels were determined using RT and qPCR primer/probe sets speciﬁc for the NP, NS1, PB1, M1 and M2 genes. b–d ATG5DD cells, with or
without Sh1 treatment, were infected with IAV for 16 h at the indicated MOI. The gating strategy after nucleoprotein (NP) immunostaining and ﬂow
cytometry is shown for two samples: uninfected, and infected at an MOI of 7 (b). The percentage of NP-expressing cells (c) and the geometric mean
ﬂuorescent intensity (GMFI) of NP per cell (d) were determined by ﬂow cytometry. e, f IAV M2 expression was determined using ﬂow cytometry (e)
and immunoblotting (f) following 16 or 20 h infection at the indicated MOI, respectively. g ATG5DD cells, pretreated or not with Shield1 (Sh1), were
infected for 16 h at the indicated MOI. NP RNA expression in supernatants was analysed by RT–qPCR. h ATG5DD cells, pretreated or not with Shield1
(Sh1), were infected at MOI 3 for the indicated times; haemagglutination assays were used to quantify of the number of haemagglutinin units (HAUs)
per millilitre of supernatant. i Atg5+/+ or Atg5–/– were infected with IAV at the indicated MOI for 16 h. Percentages of NP-expressing cells was
determined by ﬂow cytometry. Graphs show mean and standard deviation of biological triplicates, and data are representative of two experiments.
ns, not signiﬁcant (one-tailed unpaired t-test followed by Holm’s multiple testing correction)
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ROS content. Measurement of both total and mitochon-
drial ROS revealed that Shield1 treatment did not impact
ROS content, arguing that differences in ROS are not
responsible for the hyperinﬂammatory phenotype of
autophagy-incompetent cells (Supplementary Figure S4).
We next investigated whether NS1, a key negative reg-
ulator of the type I IFN response47, played a role in the
suppression of ISGs following infection. We infected cells
with wild type and ΔNS1 IAV PR8 in the presence or
absence of Shield1. Stabilization of ATG5DD decreased
CD274 expression following infection with either viral
strain (Fig. 4f).
ATG5 mediates several non-autophagy-related pheno-
types48. Thus we generated an Atg5–/– cell line that stably
expressed the mutant ATG5 molecule, ATG5K130RDD.
ATG5 lysine K130 is an amino acid required for binding
to ATG12, thus ATG5K130R cannot form the
ATG5–ATG12 complex. We conﬁrmed that
ATG5K130RDD accumulated upon Shield1 treatment
(Supplementary Figure S5). However, as expected, we did
not detect a band corresponding to the ATG5–ATG12
complex in Shield1-treated cells. LC3-II was also unde-
tectable (Supplementary Figure S5). We infected
ATG5K130RDD cells in the presence or absence of Shield1
and observed that lysine 130 of ATG5 was required for
suppression of CD274 expression (Fig. 4g). We estab-
lished Atg7–/– cell lines, which stably expressed ATG7DD,
thus permitting controlled regulation of a distinct step in
autophagy. The ATG7 protein is required for ATG5
conjugation to ATG12 during autophagosomal mem-
brane elongation49. Conﬁrming that ATG7 was stabilized,
Shield1 treatment permitted ATG5–ATG12 complex
formation, rendering the cell line competent for autop-
hagy as measured by the LC3-II/LC3-I ratio (Supple-
mentary Figure S5). Validating our ﬁndings in the
ATG5DD cell line, we demonstrated that ATG7DD stabi-
lization also resulted in reduced CD274 expression in
infected cells (Fig. 4h). Together, we conclude that
Fig. 3 IAV-induced expression of type I IFN-stimulated genes is reduced when ATG5DD is stabilized. a ATG5DD cells, pretreated for 16 h with
Shield1 (Sh1), were infected with IAV PR8 at MOI 3 for 4 or 12 h followed by RNA extraction. mRNA levels of 561 genes (see Materials and methods)
were quantiﬁed using Nanostring nCounter technology. Volcano plots show the p-value determined by two-tailed paired t-tests and fold change of
gene expression in control vs. Sh1-treated cells. Iso z-value curves are depicted. Data were generated from three independent experiments. b Gene
set enrichment analysis was performed after ranking genes according to their differential expression in control vs. Sh1-treated samples (see Materials
and methods for computation of t-statistic). Shown are normalized enrichment score and p-values, computed by the GSEA method40. Each point
represents a gene set (the 40 most enriched gene sets are shown), and sets with an enrichment false-discovery rate <0.2 are coloured and labelled. c
The 44 genes most signiﬁcantly impacted by Sh1 treatment (paired t-test p-value <0.05) were selected and weighted by their t-statistic, which gave
rise to an “autophagy” vector lying in a 44-dimensional space (red). Data from whole-blood stimulation were used to create an IFN-β vector (control
vs. IFN-β treatment t-statistic, green) and an IFN-γ vector (control vs. IFN-β treatment t-statistic, purple), after which all vectors were normalized to
length 1. d Bootstrapping over the 25 donors of the whole-blood study was performed and the difference 〈autophagy, IFN-β〉−〈autophagy, IFN-γ〉
between the two scalar products was computed for each iteration. Plotted is the distribution of the differences, with a 95% conﬁdence interval of
(0.014, 0.12)
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Fig. 4 ISG expression levels are suppressed by autophagy machinery during IAV infection. a ATG5DD cells, pretreated or not with Shield1 (Sh1)
for 16 h, were infected with IAV at the indicated MOIs for 5 h. CXCL10 concentration in the supernatants was measured by ELISA. b, c ATG5DD cells,
pretreated or not with Sh1 for 20 h, were infected with IAV at the indicated MOIs for 16 h. Surface expression of CD274 (b) and H-2Kb (c) was
measured by ﬂow cytometry. d ATG5DD cells, pretreated or not with Sh1 for 20 h, were infected with IAV PR8 at the indicated MOIs for 20 h before
analysing PSMB10 expression by immunoblot. e ATG5DD cells, pretreated or not with Sh1 for 16 h and with anti-IFNAR1 antibody for 1 h, were
infected for 5 h at the indicated MOIs and Cd274 expression was assayed by RT–qPCR (calculated as 2(CtHprt1−CtCd274)). f ATG5DD cells, pretreated or
not with Sh1 for 20 h, were infected with PR8 or ΔNS1 PR8 at the indicated MOIs for 16 h before measuring CD274 surface expression by ﬂow
cytometry. g, h ATG5K130RDD (g) or ATG7DD (h) cells were treated as in b and c before monitoring of surface CD274 expression by ﬂow cytometry. a–
c, e–h Graphs show mean and standard deviation of three biological replicates, and data are representative of three experiments. ns, not signiﬁcant;
*q < 0.05, **q < 0.01, ***q < 0.001, ****q < 0.0001 (one-tailed unpaired t-test followed by Holm’s multiple testing correction)
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ATG5–ATG12 complex formation is a key step in limit-
ing ISG induction in response to IAV infection.
Early post-infection, virus-induced autophagy decreases
IFN-β expression leading to diminished ISG expression
Based on the differential expression of ISGs, we con-
sidered two possible hypotheses: that autophagy nega-
tively impacted IFNAR signalling or, alternatively, that
IAV-infected, autophagy-competent cells produced less
IFN-β. To address the ﬁrst possibility, we directly tested
whether autophagic ﬂux impacted IFNAR signalling.
Following treatment with Shield1 or vehicle for 16 h,
ATG5DD cells were exposed to increasing concentrations
of recombinant IFN-β. CD274 and H-2Kb expression was
equally increased following IFN-β treatment, suggesting
that ATG5DD stabilization did not alter IFNAR signalling
(Fig. 5a, b). To test our alternate hypothesis, we treated
cells with IFNAR blocking antibody and observed by
reverse transcription–quantitative polymerase chain
reaction (RT–qPCR) that ATG5DD stabilization inhibited
Ifnb1 expression independently of IFNAR signalling
(Fig. 5c). Importantly, we previously determined that
RT–qPCR was sensitive enough to detect fold changes as
small as 1.4 with 80% power using triplicate samples, thus
permitting conﬁrmation of the results we observed in the
nCounter analysis (Supplementary Figure S6). ATG5DD
stabilization resulted in reduced IFN-β expression as early
as 1.5 h post-infection (Fig. 5d). Early IFN-β expression in
the context of virus infection relies on nuclear factor-
kappaB (NF-κB) activation50. To determine the upstream
signalling events impacted by autophagy, we measured
NF-κB activation through IκBα degradation and NF-κB
reporter assay, observing that autophagy limited IAV-
induced NF-κB activation (Fig. 5e–g). We then tested
whether autophagy was induced by IAV at this early time
point. LC3-II/LC3-I ratio was increased at 1 h post-
infection correlating with decreased levels of p62 when
Shield1 was present. These ﬁndings argue that autophagy
was rapidly induced and that IAV-mediated inhibition of
autophagy maturation occurred later in the viral life cycle
(Fig. 6a, see also Fig. 1j). Interestingly, the ATG5–ATG12
complex limits VSV-induced type I IFN51. We assessed
whether the ATG5–ATG12 complex was sufﬁcient to
modulate type I IFN or, alternatively, whether the effect
required autophagosome maturation. We treated cells
with thapsigargin, which blocks autophagosome matura-
tion without preventing ATG5–ATG12 conjugation52. As
expected, thapsigargin treatment potentiated LC3-II
accumulation and prevented p62 degradation in cells
where ATG5DD was stabilized (Fig. 6b) but did not inhibit
ATG5DD–ATG12 complex formation (Fig. 6b). Notably,
treatment with thapsigargin abrogated the negative
impact of autophagy on the expression of Ifnb1 and
induced expression of CD274 (Fig. 6c, d). Thus we
concluded that induction of autophagy by IAV at early
time points in the viral life cycle inhibits IFN-β induction.
This inhibitory effect was independent of NS1 and
required autophagosome maturation.
Discussion
Our study describes the generation of a cellular model
in which the capacity of a cell to undergo autophagy can
be dynamically restored within 1 h after addition of a
small, immunologically inert molecule. Currently avail-
able models, on the contrary, do not enable rapid
manipulation of the autophagy pathway and are con-
founded by off-target effects24–33, 53–55. The development
of a rapid autophagy restoration system permitted us to
dissect the impact of autophagy perturbation on inﬂam-
matory responses to viral infection. One important caveat,
however, is that, under selected conditions, we observed
low levels of ATG5DD and autophagic activity in cells in
which we did not rescue the destabilized ATG5DD.
However, cells in which ATG5DD was stabilized through
Shield1 had autophagy levels that were comparable to that
of WT MEFs, and untreated cells exhibited a marked
decrease in autophagic activity.
Using this model system, we demonstrated that the
absence of ATG5 did not impact IAV infectivity or
replication, yet the induction of ISGs, such as CD274 and
MHC I, were diminished as a result of IAV-induced
autophagy. With respect to regulation of MHC I, we
suggest that the negative impact of autophagy (secondary
to ATG5DD stabilization) is mediated by decreased
expression of two MHC I presentation pathway genes,
Psmb10 and Tap1 (see also Table S1). These ﬁndings are
in agreement with a report that autophagy-deﬁcient
dendritic cells express higher levels of MHC I on their
surface at steady state and more efﬁciently prime anti-
IAV-speciﬁc CD8+ T-cell responses56. Of note, even
though autophagy limited the induction of ISGs, we did
not detect any impact on IAV replication at later time
points. This may be a reﬂection of a key anti-IAV ISG,
MX1, being inactive in our cells57, 58. Alternatively, we
may not observe the impact of ISGs due to our experi-
mental approach focussing on the ﬁrst cycle of replica-
tion, a direct result MEFs lacking the protease activity
required cleave haemagglutinin and generate replication
competent viral progeny59, 60.
The decreased expression of key proteins involved in
immune regulation correlated with decreased of Ifnb1
expression and lower NF-κB activation. Interestingly, the
best-described mechanism by which IAV inhibits pattern
recognition receptor signalling and subsequent IFN-β and
ISG induction is through the action of NS161–63. Using
IAV lacking expression of NS1, we conﬁrm that the
mechanisms reported here are novel and likely apply to
early inﬂammatory responses occurring prior to NS1
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expression. Importantly, while we showed that autophagy
did not require NS1 to reduce IFN-β activity, inhibition of
IFN-β by NS1 may rely in part on NS1-mediated autop-
hagy stimulation in the infected cell64. Of note, even
though we observed that autophagy competency did not
impact the cell response to IFN-β within IAV-infected
cells, autophagy perturbation may impact other cytokine
pathways.
Future studies will be important to determine the role
during the early phases of infection. As the inﬂammatory
response to IAV impacts viral propagation and symptom
severity, we suggest that autophagy-mediated suppression
of inﬂammation represents a host mechanism to limit
acute pathology.
Materials and methods
Cell lines, cell growth media, treatments and viruses
Atg5+/+ cells and Atg5–/– MEFs were obtained from
Christian Munz, University of Zurich, Switzerland. Atg7–/
– MEFs were obtained from Stephen Tait, University of
Glasgow. All cell lines in this study were cultivated in
complete growth medium, comprised of Dulbecco’s
modiﬁed Eagle’s medium with high glucose, pyruvate and
GlutaMAX and supplemented with non-essential amino-
acids, HEPES buffer, penicillin/streptomycin (all reagents,
ThermoFisher Scientiﬁc) and 10% foetal calf serum (GE
Healthcare, A15-502). Shield1 (Clontech, 632188) was
added at a ﬁnal concentration of 1 µM (stock maintained
at 1 mM) in growth media. Ethanol, the solvent for
Shield1, was used as a control at a 1:1000 dilution in
growth media. Treatments were used at the following
concentrations: chloroquine (Sigma, C6628), 50 µM;
PP242 (Selleck Chemical, S2218), 1 µM; MG132 (Sigma,
C2211) 10 µM; recombinant IFN-β, at the indicated
concentrations (BioLegend, 581302); and thapsigargin
(Sigma, T9033) 3 µg/mL. Blocking IFNAR antibody (BD
Pharmingen, 561183) or isotype control (BD Pharmingen,
553447) were used at 10 µg/mL and added to culture
media 1 h before infection for the duration of the
Fig. 5 ATG5DD stabilization inhibits ISG expression via cell-
intrinsic modulation of IFN-β expression and not through
desensitization to IFNAR signalling. a, b ATG5DD cells, pretreated or
not with Shield1 (Sh1), were treated with recombinant mouse IFN-β at
the indicated concentration for 6, 10 or 20 h, followed by surface
expression analysis of CD274 (a) and H-2Kb (b) by ﬂow cytometry. c
ATG5 DD cells were pretreated with anti-IFNAR1 antibodies followed
by IAV infection. Ifnb1 expression was assayed by RT–qPCR. d In
independent experiments, Ifnb1 induction was measured at 1.5 and
3.5 h post-infection in autophagy-competent (Sh1) vs. autophagy-null
cells (∅). e, f ATG5DD cells, pretreated or not with Shield1 (Sh1), were
infected with IAV for 1 h before monitoring IκBα degradation by
immunoblot (e) and quantiﬁcation with ImageJ (f). g ATG5DD cells
transfected with NF-κB transcription activity GFP reporter for 20 h
were pretreated or not with Shield1 (Sh1) and infected with IAV.
Incucyte intra-incubator microscope allowed the monitoring of GFP-
positive cells. a–d, f, g Graphs show mean and standard deviation of
three (a–d, f) or four (g) biological replicates, and data are
representative of three experiments. ns, not signiﬁcant; *q < 0.05, **q
< 0.01 (one-tailed unpaired t-test followed by Holm’s multiple testing
correction)
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experiment. Inﬂuenza A/PR/8/76 (PR8) and ΔNS1 PR8
were purchased as puriﬁed allantoic ﬂuid or puriﬁed
antigen, respectively, from Charles River Laboratories
(Spafas, CT, USA).
Lentivirus production and clonal stably modiﬁed cell line
generation
pLVX pTuner lentiviral vector (Clontech) with a pur-
omycin resistance gene and destabilization domain at the
5’P end of the multiple cloning site was from Clontech.
Mutagenesis PCR allowed the introduction of an AgeI site
and 3 glycin codons (to increase ﬂexibility between the
DD and ATG5 protein) at the 5’-terminus of the ATG5
coding site in the pmCherry–ATG5 plasmid (Plasmid
#13095; Addgene). Mutagenesis qPCR was performed
using Phusion polymerase (ThermoFisher Scientiﬁc) fol-
lowing the manufacturer’s protocol and using primers:
ACCGGTGGAGGAGGAACAGATGACAAAGATGTG
CTT and CATGGTACCGTCGACTG. The ATG5DD
coding insert was then cleaved by AgeI and BamHI
restriction enzymes and ligated into the pLVX pTuner
lentiviral vector (all enzymes, New England Biolabs). The
ﬁnal plasmid (pATG5DD) was conﬁrmed to have the
expected sequence.
For the generation of the ATG5K130RDD coding plas-
mid, mutagenesis PCR was performed using Phusion
polymerase to change codon 130 from AAA to CGA in
the pATG5DD plasmid with the primers: CGA-
GAAGCTGATGCTTTAAAGCA and ATACACGACA-
TAAAGTGAGCC. pBabeATG7DD, a retroviral vector
coding for ATG7DD, was a generous gift from Douglas
Green, St. Jude Children’s Research Hospital and Stephen
Tait, University of Glasgow. Lentiviruses (from pATG5DD
and pATG5K130RDD) and retroviruses (pATG7DD) were
produced and Atg5–/– or Atg7–/– MEFs were infected.
Puromycin was used at 4 µg/mL for 1 week for selection
(ThermoFisher Scientiﬁc, A11138-03) before single-cell
cloning and phenotyping were performed.
Virus infection
For infection, adherent cells were washed with growth
medium without foetal calf serum. Growth medium,
without serum, containing IAV or CHIKV was added to
cells and plates were incubated at 37 °C for 1 h with gentle
shaking every 15min. Cells were then washed with
complete growth medium before adding fresh complete
growth medium with or without additional treatments.
Immunoblotting
Cells were harvested by trypsinization, centrifuged and
resuspended in 100 µL per million cells in lysis buffer: 1%
Nonidet P40 substitute (Sigma, 74385) with protease
inhibitor (Sigma, 11836145001). Protein concentration in
the resulting supernatants was determined by BCA assay
(ThermoFisher Scientiﬁc, 23225) following lysis on ice
and clariﬁcation by centrifugation according to the
manufacturer’s guidelines. In all, 30 µg of protein per
sample were prepared in Lithium Dodecyl Sulphate
sample buffer (ThermoFisher Scientiﬁc, NP0007) with
dithiothreitol (20 mM ﬁnal concentration) and loaded in
4–12% gradient polyacrylamide gel (Biorad, 3450124).
Following transfer, polyvinylidene ﬂuoride membranes
(BioRad, 1704157) were blocked for 1 h in 5% w/v non-fat
dry milk in TBS with 0.05% Tween 20 (Sigma P5927)
(blocking solution). Membranes were then incubated for
15 h in 1:1000 dilution of the following antibodies in
Fig. 6 Autophagy must go to completion to inhibit IFN-β
expression. a ATG5DD cells were pretreated or not with Sh1 for 16 h
and infected with IAV at the indicated MOIs. One hour post-infection,
p62, LC3-I, LC3-II and GAPDH levels were measured by immunoblot.
Three biological replicates were run for infected control or Sh1-treated
samples. b ATG5DD cells were pretreated or not with Sh1 for 16 h and
infected with IAV at the indicated MOIs, with or without thapsigargin
(Thaps) for 5 h. p62, LC3-I, LC3-II, ATG5–ATG12 and GAPDH levels were
measured by immunoblot. c ATG5DD cells were pretreated or not with
Sh1 and infected with IAV at the indicated MOIs, with or without
thapsigargin. Three hours post-infection, Ifnb1 expression was assayed
by RT–qPCR. d ATG5DD cells were pretreated or not with Sh1 and
infected with IAV. Sixteen hours post-infection, surface CD274
expression was monitored by ﬂow cytometry. c, d Graphs show mean
and standard deviation of three biological replicates, and data are
representative of three experiments. ns, not signiﬁcant; *q < 0.05, **q
< 0.01, ***q < 0.001 (one-tailed unpaired ∅ followed by Holm’s
multiple testing correction)
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blocking solution with gentle shaking at 4 °C: anti-ATG5
(Abcam, ab108327), anti-GAPDH (CST, 2118), anti-LC3B
(CST, 2775 S), anti-p62 (CST, 5114), anti-M2 (Abcam,
ab5416), anti-IκBα (CST, 9242), and anti-PSMB10
(Abcam, ab77735) antibodies. Membranes were then
incubated in 1:1000 horseradish peroxidase-conjugated
anti-mouse antibody (CST, 7076 S) or anti-rabbit anti-
body (CST, 7074 S) in blocking solution for 1 h at room
temperature with gentle shaking. Membranes were
revealed with Supersignal Enhanced Chemoluminescence
Substrate (ThermoFisher Scientiﬁc, 34080) according to
the manufacturer’s guidelines and exposed to ﬁlm.
Intra-incubator microscopy
To monitor cell growth, cells were plated at 10,000 cells
per well in 24-well plates. To monitor infection of cells by
CHIKV harbouring a green ﬂuorescent protein (GFP)
coding sequence after the subgenomic promoter (a kind
gift of Marco Vignuzzi, Institut Pasteur), 200,000 cells
were plated in 12-well plates 24 h before infection. To
monitor NF-κB transcription factor activity, cells were
transfected with pNF-κB–GFP plasmid (a kind gift from
Eliane Meurs, Institut Pasteur) using lipofectamine 2000
(ThermoFisher Scientiﬁc, 11668027) according to the
manufacturer’s guidelines 24 h before plating (200,000
cells were plated in 12-well plates) and 40 h before
infection. Images were taken every hour using Incucyte
ZOOM System and analysis was performed using Incu-
cyte ZOOM software (EssenBioScience).
Flow cytometry and imaging ﬂow cytometry
Cells were harvested and washed as for immunoblot-
ting. After washing, cells were incubated for 20min in
1:500 dilution of LIVE/DEAD Fixable Violet Dead Cell
Stain (ThermoFisher, L34955) in phosphate-buffered
saline (PBS), then 30min in 1:100 antibody dilution for
surface staining, all at 4 °C. Antibodies included
allophycocyanin-conjugated anti-mouse CD274 (BD
Pharmingen, 564715) or PE-conjugated anti-mouse H-
2Kb (BD Pharmingen, 553570).
For intracellular staining (ICS), cells were ﬁxed using
BD Cytoﬁx/Cytoperm Fixation and Permeabilization
Solutions (BD Biosciences, 554722). Cells were then
washed twice in BD Perm/wash buffer (PWB, BD Bios-
ciences, 554723). Immunostaining was performed at 4 °C
for 45 min with 1:100 dilution of ﬂuorescein iso-
thiocyanate (FITC)-conjugated anti-IAV NP antibody
(Abcam, ab20921) or 1:500 dilution of anti-IAV M2
protein antibody (Abcam, ab5416) in PWB for 45min at
4 °C. For M2 staining, cells were then incubated in 1:500
dilution of Alexa Fluor 647 goat anti-mouse IgG (H+L)
(Jackson ImmunoResearch, 115-606-062) for 45min at 4 °
C. Cells were then washed in PWB buffer twice and in
PBS once before resuspension in PBS and acquisition
using a BD LSR Fortessa ﬂow cytometer. Data analysis
was performed using FlowJo 9 (Flowjo, LLC).
For imaging ﬂow cytometry, the antibodies used for ICS
were: mouse anti-LC3 antibody (MBL International) at
1:500 dilution and rabbit FITC-conjugated anti-IAV NP
antibody (Abcam, ab20921) at 1:100 dilution. Staining of
LC3 was performed before washing and staining with
Alexa Fluor 647 goat anti-mouse IgG (H+L) (Jackson
ImmunoResearch, 115-606-062). After washes, the anti-
NP antibody was introduced. Cells were then washed in
PWB buffer twice and in PBS once before resuspension in
PBS and acquisition using Amnis Imagestream X imaging
ﬂow cytometer. Data analysis was performed using the
Ideas software (Amnis); the masking strategy and the
metric (bright detail intensity R3 or BDI R3) used to
measure autophagic activity were previously described65.
RNA extraction, RT and qPCR
For RNA extraction, cells were harvested and washed as
for protein extraction. High pure RNA Isolation Kit (Roche,
11828665001) was used to extract RNA according to the
provider’s protocol. For IAV RNA extraction from super-
natants, 200 µL of supernatants cleared of cell debris by
centrifugation at 1500 × g for 5min at 4 °C were used
instead of the 200 µL cell suspension in PBS at the ﬁrst step
of Roche’s protocol. RT was performed using Maxima
reverse transcriptase (ThermoFisher Scientiﬁc, catalogue
number: EP0741) and random primers (ThermoFisher
Scientiﬁc, SO142). Taqman primer/probe mixes were used
for cDNA quantiﬁcation of Hprt1 (Mm03024075_m1),
Ifnb1 (Mm00439546_s1), Cd274 (Mm00452054_m1) and
Cxcl10 (Mm00445235_m1). For viral gene detection, we
designed the following primer/probe sets:































Custom gene expression assays were synthesized by
ThermoFisher Scientiﬁc. In all, 2 µL of cDNA diluted 4
times in water was used at concentration per qPCR
reaction. qPCR was performed using Taqman Fast
Advanced Master Mix (ThermoFisher Scientiﬁc) accord-
ing to the provider’s protocol. StepOnePlus Real-Time
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PCR System (ThermoFisher Scientiﬁc) was used for
thermocycling and data acquisition using the Fast
Advanced Master Mix recommended conditions. The
StepOnePlus software (ThermoFisher Scientiﬁc) was used
for analysis.
Haemagglutination assay
In all, 100 µL of two-fold serial dilutions (in PBS
CaCl2
−MgCl2
−) of infected cell supernatants were mixed
with 100 µL of 0.5% Guinea pig blood (Charles River
Laboratories) in PBS CaCl2
−MgCl2
− in round-bottom 96-
well plates before incubation for 2 h at 4 °C. The hae-
magglutinin titre was calculated as the dilution of the
most diluted well where red blood cell agglutination was
visible.
Power calculation for RT–qPCR
Standard deviation of Ct values did not show mean
dependence. We therefore modelled Ct values of technical
replicates for gene i as independent normally distributed
random variables with mean μi and standard deviation σ
(this latter parameter being independent of the gene).
Estimation of σ was performed using pooled variance.
RNA levels are compared using normalized data (ΔCt
values), and by error propagation, ΔCt values follow a
normal distribution with standard deviation σ’= √2 σ.
The power curve was computed using the function power.
t.test in R (CRAN), with parameters sd= σ’, power= 0.8,
sig.level= 0.05 and delta= log2(fold change).
Nanostring nCounter assays, normalization and analysis
Infected cells were harvested and RNA was extracted as
detailed above. nCounter Mouse Immunology Kit was
used, following Nanostring guidelines. Raw RNA counts
were exported from the nSolver Analysis Software
(Nanostring). Raw RNA counts were normalized by
housekeeping genes to account for the inter-sample var-
iation of RNA quantity. The selected housekeeping gene
pool was built from the 14 candidate control genes pro-
vided by Nanostring, following the geNorm method39.
Brieﬂy, for each two genes j ≠ k, pairwise variation coef-






where aij is the number of counts for the gene j in the
sample i. The gene stability measure Mj for control gene j
is the arithmetic mean of all pairwise variations Vjk for k ≠
j. Mj evaluates the degree of correlation of gene j to other
control genes (the smaller Mj is, the more correlated gene
j is to other control genes). Genes were ranked by
increasing M (Figure S2A), and to determine a threshold,
the normalization factors NFn was computed for all n
(deﬁned as the geometric mean of the housekeeping gene
counts) of each sample when considering the n genes with
lowest M as a housekeeping gene set (Figure S2B). Cor-
relations between consecutive normalization factors
increased then decreased when adding the sixth gene with
lowest M (Figure S2C). This threshold was conﬁrmed by
studying the pairwise variation between consecutive NFns
(data not shown). The ﬁnal housekeeping gene set con-
sisted of the following ﬁve genes: Ppia, Gapdh, Rpl19,
Oaz1, and Polr2a. Normalization was performed as fol-
lows: the scaling factor for a sample was deﬁned as the
ratio of the average across all geometric means and the
geometric mean of the sample. For each sample, all gene
counts were multiplied by the corresponding scaling
factor.
As protein and mRNA data are generally close to log-
normally distributed66, normalized RNA counts were
subsequently log-transformed. For each time point, only
genes that were consistently expressed above the lower
limit of quantiﬁcation were tested. Paired t-tests, which
are shown to be extremely robust against non-
normality67, were performed to compare Shield1-treated
vs. untreated mRNA (log-transformed) normalized copy
numbers. z-score was deﬁned as
z ¼ log10 p valueð Þ ´ log2 fold changeð Þ
 
:
Gene set enrichment analysis
Each gene was scored using the absolute value of the
sum of the t-statistics from paired t-tests at 4 and 12 h.
Genes were ranked by decreasing score, and gene set
enrichment analysis was performed using GSEA v. 2.2.1
(Broad Institute), with the following settings: method, pre
ranked gene list; gene setsdatabase, reactome (c2.cp.
reactome.v5.1.symbols.gmt); number of permutations,
10,000; enrichment statistic, classic; min set size, 5; max
set size, 100; and all other parameters as default.
Quantitative approach to distinguish between IFN-β and
IFN-γ signatures
Genes present in both nCounter panels (mouse
immunology in this study and human immunology v.2 for
the human whole blood study41) and consistently
expressed above the lower limit of quantiﬁcation were
considered. Those for which the EtOH vs. Shield1 t-test
p-value was <0.05 at 12 h were selected and weighted by
their t-statistic, resulting in a 44-dimensional vector that
was subsequently normalized by its L2 norm. Similar
vectors were obtained by weighting the same 44 genes by
the t-statistic from t-test comparing control vs. IFN-β or
control vs. IFN-γ in the human whole blood study, after
which they were also normalized. The difference 〈autop-
hagy, IFN-β〉−〈autophagy, IFN-γ〉 between the scalar
products was computed for 100,000 iterations through
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bootstrapping over the 25 donors of the whole-blood
study.
ELISA
CXCL10 ELISAs (R&D Biosystems, DY466) were per-
formed using cell supernatant clariﬁed by spinning at
850 × g for 5 min.
Statistical analysis
Given that Shield1 treatment resulted in the reduced
expression of ISGs (Fig. 3), statistical analysis in the
subsequent ﬁgures (Figs. 4 and 5) was performed using
one-tailed t-tests to test for downregulation of ISG
expression upon Shield1 treatment. t-Tests were per-
formed using GraphPad Prism 6 (Figs. 2, 4 and 5) or R
(Fig. 3), and multiple testing correction was performed
using R.
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